Gilead Sciences, Inc.
US ˙ NasdaqGS ˙ US3755581036

SecurityGILD / Gilead Sciences, Inc.
InstitutionDavis R M Inc
Latest Disclosed Ownership2,174 shares
Latest Disclosed Value $ 302,991
Davis R M Inc reports 26.10% increase in ownership of GILD / Gilead Sciences, Inc.

On May 13, 2026 - Davis R M Inc filed a 13F-HR form disclosing ownership of 2,174 shares of Gilead Sciences, Inc. (US:GILD) valued at $302,990 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 1,724 shares of Gilead Sciences, Inc.. This represents a change in shares of 26.10% during the quarter. The current value of the position is $280,424 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F GILEAD SCIENCES COM 375558103 2,174 450 26.10 303 43.13 0.0054
2026-02-12 2025-12-31 13F Gilead Sciences COM 375558103 1,724 -170 -8.98 212 0.48 0.0036
2025-11-12 2025-09-30 13F Gilead Sciences COM 375558103 1,894 1,894 210 0.0037
2021-05-10 2021-03-31 13F Gilead Sciences COM 375558103 0 -3,721 -100.00 0 -100.00
2021-01-27 2020-12-31 13F Gilead Sciences COM 375558103 3,721 391 11.74 217 3.33 0.0062
2020-12-01 2020-09-30 13F Gilead Sciences COM 375558103 3,330 -300 -8.26 210 -24.73 0.0069
2020-07-20 2020-06-30 13F Gilead Sciences COM 375558103 3,630 598 19.72 279 22.91 0.0099
2020-04-24 2020-03-31 13F Gilead Sciences COM 375558103 3,032 -2,000 -39.75 227 -30.58 0.0094
2020-01-23 2019-12-31 13F Gilead Sciences COM 375558103 5,032 370 7.94 327 10.85 0.0107
2019-10-24 2019-09-30 13F Gilead Sciences COM 375558103 4,662 4,662 295 0.0104
2018-07-19 2018-06-30 13F GILEAD SCIENCES COM 375558103 0 -9,757 -100.00 0 -100.00
2018-04-19 2018-03-31 13F GILEAD SCIENCES COM 375558103 9,757 -2,866 -22.70 736 -18.58 0.0293
2018-01-16 2017-12-31 13F GILEAD SCIENCES COM 375558103 12,623 -5,832 -31.60 904 -39.53 0.0354
2017-10-24 2017-09-30 13F GILEAD SCIENCES COM 375558103 18,455 519 2.89 1,495 17.72 0.0618
2017-07-31 2017-06-30 13F GILEAD SCIENCES COM 375558103 17,936 -26,013 -59.19 1,270 -57.45 0.0537
2017-05-03 2017-03-31 13F GILEAD SCIENCES COM 375558103 43,949 -65,189 -59.73 2,985 -61.80 0.1349
2017-01-18 2016-12-31 13F GILEAD SCIENCES COM 375558103 109,138 -75,526 -40.90 7,815 -46.51 0.3735
2016-10-19 2016-09-30 13F GILEAD SCIENCES COM 375558103 184,664 -33,509 -15.36 14,611 -19.72 0.7127
2016-07-14 2016-06-30 13F GILEAD SCIENCES COM 375558103 218,173 -8,300 -3.66 18,200 -12.52 0.8943
2016-04-18 2016-03-31 13F GILEAD SCIENCES COM 375558103 226,473 22,270 10.91 20,804 0.68 1.0592
2016-01-14 2015-12-31 13F GILEAD SCIENCES COM 375558103 204,203 15,887 8.44 20,663 11.75 1.0566
2015-10-16 2015-09-30 13F GILEAD SCIENCES COM 375558103 188,316 26,250 16.20 18,491 -2.55 0.9880
2015-07-16 2015-06-30 13F GILEAD SCIENCES COM 375558103 162,066 38,077 30.71 18,975 55.95 0.9802
2015-04-17 2015-03-31 13F GILEAD SCIENCES COM 375558103 123,989 76,676 162.06 12,167 172.80 0.6400
2015-01-23 2014-12-31 13F GILEAD SCIENCES COM 375558103 47,313 42,433 869.53 4,460 759.34 0.2458
2014-10-20 2014-09-30 13F/A-2 GILEAD SCIENCES COM 375558103 4,880 1,172 31.61 519 86.69 0.0298
2014-10-20 2014-09-30 13F/A-1 GILEAD SCIENCES COM 375558103 4,880 0 519 0.0298
2014-01-27 2013-12-31 13F GILEAD SCIENCES COM 375558103 3,708 3,708 278 0.0170
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.